https://www.fda.gov/media/88254/download. (accessed 22.04.2020).
22. US Food and Drug Administration. Draft guidance on progesterone,
2011. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/psg/Progesterone_caps_19781_RC02-11.pdf(accessed 22.04.2020).
23. European Medicine Agency. Guideline on the investigation of
bioequivalence, 2010. Available at:https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf(accessed 22.04.2020).
24.Davit B, Chen M-L, Conner DP et al. Implementation of a
reference-scaled average bioequivalence approach for highly variable
generic drug products by the US Food and Drug Admininstration. AAPS J .
2012;14:915–924.
25. National Medical Products Administration. Technical guidelines for
bioequivalence study of highly variable drugs,2018. Available at:http://www.nmpa.gov.cn/WS04/CL2093/331454.html.
(accessed 22.04.2020).